Cargando…

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers

Despite the introduction of novel agents, multiple myeloma remains incurable for most patients, necessitating further therapeutic options. Venetoclax, a selective BCL-2 inhibitor, had shown promising results in patients with translocation t(11;14), but questions remain open about its optimal use. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szita, Virág Réka, Mikala, Gábor, Kozma, András, Fábián, János, Hardi, Apor, Alizadeh, Hussain, Rajnics, Péter, Rejtő, László, Szendrei, Tamás, Váróczy, László, Nagy, Zsolt, Illés, Árpád, Vályi-Nagy, István, Masszi, Tamás, Varga, Gergely
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918485/ https://www.ncbi.nlm.nih.gov/pubmed/35295611 http://dx.doi.org/10.3389/pore.2022.1610276

Ejemplares similares

Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers
por: Varga, Gergely, et al.
Publicado: (2021)

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program
por: Varga, Gergely, et al.
Publicado: (2019)

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary
por: Lovas, Szilvia, et al.
Publicado: (2022)

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax
por: Kotmayer, Lili, et al.
Publicado: (2023)

The Impact of Beta-Catenin and glutathione-S-transferase Gene Polymorphisms on the Treatment Results and Survival of Multiple Myeloma Patients
por: Pál, Ildikó, et al.
Publicado: (2019)

Venetoclax for the treatment of translocation (11;14) AL amyloidosis
por: Sidiqi, M. Hasib, et al.
Publicado: (2020)

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers
por: Balikó, Anett, et al.
Publicado: (2023)

Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma
por: Nagy, Ákos, et al.
Publicado: (2020)

Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma
por: Wiedemann, Ádám, et al.
Publicado: (2023)

PB2104: SOLUBLE B-CELL MATURATION ANTIGEN AS A MONITORING MARKER FOR MULTIPLE MYELOMA
por: Wiedemann, Ádám, et al.
Publicado: (2023)

Fatal CMV-Infection after Autologous Stem Cell Transplantation in Refractory Systemic Lupus Erythematosus
por: Váróczy, László, et al.
Publicado: (2012)

Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation
por: Jóna, Ádám, et al.
Publicado: (2016)

Hungarian and Indonesian rice husk as bioadsorbents for binary biosorption of cationic dyes from aqueous solutions: A factorial design analysis
por: Sukmana, Hadid, et al.
Publicado: (2023)

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
por: Premkumar, Vikram J., et al.
Publicado: (2021)

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
por: Nguyen, Nina, et al.
Publicado: (2022)

Effect of Fcγ-receptor 3a (FCGR3A) gene polymorphisms on rituximab therapy in Hungarian patients with rheumatoid arthritis
por: Pál, Ildikó, et al.
Publicado: (2017)

P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
por: Bátai, Bence, et al.
Publicado: (2023)

Targeting BCL‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma
por: Kaufman, Jonathan L., et al.
Publicado: (2021)

Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer
por: Madar, László, et al.
Publicado: (2023)

Changing Patterns in the Clinical Pathological Features of Hodgkin Lymphoma: A Report from Debrecen, Hungary
por: Miltényi, Zsófia, et al.
Publicado: (2011)

Genetic diversity of Hungarian canine distemper virus strains
por: Demeter, Zoltán, et al.
Publicado: (2007)

Identification of a novel archaea virus, detected in hydrocarbon polluted Hungarian and Canadian samples
por: Molnár, János, et al.
Publicado: (2020)

5000 years of dietary variations of prehistoric farmers in the Great Hungarian Plain
por: Gamarra, Beatriz, et al.
Publicado: (2018)

Tinnitus characteristics and associated variables on Tinnitus Handicap Inventory among a Hungarian population
por: Mavrogeni, Panayiota, et al.
Publicado: (2022)

The Impact of COVID-19 on the Health and Experience of the Carers of Older Family Members Living with Dementia: An Italian–Hungarian Comparative Study
por: Kostyál, László Árpád, et al.
Publicado: (2022)

Genetic Etiology of Nonsyndromic Hearing Loss in Hungarian Patients
por: Pál, Margit, et al.
Publicado: (2023)

Criterion validity and reliability of the International Physical Activity Questionnaire – Hungarian short form against the RM42 accelerometer
por: Ács, Pongrác, et al.
Publicado: (2021)

Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group
por: Szücs, Ákos, et al.
Publicado: (2017)

Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells
por: Matula, Zsolt, et al.
Publicado: (2021)

Is “Esterhazy II”, an Old Walnut Variety in the Hungarian Gene Bank, the Original Genotype?
por: Bujdoso, Geza, et al.
Publicado: (2021)

Overview of the Hungarian National Youth Fitness Study
por: Csányi, Tamás, et al.
Publicado: (2015)

Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma
por: Basali, Diana, et al.
Publicado: (2020)

The Prevalence of Educational Neuromyths among Hungarian Pre-Service Teachers
por: Vig, Julianna, et al.
Publicado: (2023)

Do Hungarian multiple sclerosis care units fulfil international criteria?
por: Kokas, Zsófia, et al.
Publicado: (2022)

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
por: Miheller, Pál, et al.
Publicado: (2009)

Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)
por: Ceglédi, Andrea, et al.
Publicado: (2023)

PB1909: LOW-BURDEN TP53 MUTATIONS REPRESENT FREQUENT GENETIC EVENTS IN CLL WITH AN INCREASED RISK FOR TREATMENT INITIATION
por: László, Tamás, et al.
Publicado: (2023)

The Effect of Belantamab Mafodotin on Primary Myeloma–Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells
por: Matula, Zsolt, et al.
Publicado: (2023)

An appraisal: how notifiable infectious diseases are reported by Hungarian family physicians
por: Vraukó, Katalin, et al.
Publicado: (2018)

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia
por: Kövy, Petra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v49d7u4ef7rs2fgac8somh685f